Picture of Indivior logo

INDV Indivior News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

REG - Indivior PLC - Transaction in Own Shares

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240917:nRSQ4091Ea&default-theme=true

RNS Number : 4091E  Indivior PLC  17 September 2024

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

September 17, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 623,037 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from September 9, 2024, up to and
including September 13, 2024, in connection with its $100m Share Repurchase
Program. Aggregated information on the purchase of these shares can be found
in the table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 130,402,802 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (130,402,802) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 09/09/2024    LSE            69,591                                      793.53
 09/09/2024    BATE           21,276                                      792.67
 09/09/2024    CHIX           35,894                                      797.13
 09/09/2024    AQUIS          7,260                                       797.30
 10/09/2024    LSE            64,351                                      740.01
 10/09/2024    BATE           24,687                                      738.94
 10/09/2024    CHIX           37,092                                      737.86
 10/09/2024    AQUIS          7,303                                       740.16
 11/09/2024    LSE            59,097                                      726.00
 11/09/2024    BATE           30,346                                      724.24
 11/09/2024    CHIX           39,469                                      727.32
 11/09/2024    AQUIS          6,826                                       726.06
 12/09/2024    LSE            75,194                                      735.40
 12/09/2024    BATE           17,045                                      732.17
 12/09/2024    CHIX           38,959                                      735.42
 12/09/2024    AQUIS          3,969                                       735.90
 13/09/2024    LSE            49,426                                      738.86
 13/09/2024    BATE           11,525                                      737.54
 13/09/2024    CHIX           20,391                                      738.22
 13/09/2024    AQUIS          3,336                                       738.30

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSKZGMLNVRGDZM

Recent news on Indivior

See all news